 Placebo-controlled, multi-centre, randomized, double-blind dose escalation study. The aim is to evaluate the pharmacokinetics PK and safety of SMT C1100 in paediatric patients with Duchenne Muscular Dystrophy DMD who follow a balanced diet. 